During the past decade, CH René Dubos conducted 80 clinical trials. In the 10-year time frame, 80 clinical trials started and 4 clinical trials were completed, i.e. on average, 5% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 4 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH René Dubos" #1 sponsor was "Centre Hospitalier René Dubos" with 12 trials, followed by "The Lymphoma Academic Research Organisation" with 9 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 7 trials sponsored, "Groupe Francophone des Myelodysplasies" with 6 trials sponsored and "Intergroupe Francophone du Myelome" with 6 trials sponsored. Other sponsors include 91 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH René Dubos" #1 collaborator was "Ministry of Health, France" with 5 trials as a collaborator, "University Hospital, Tours" with 4 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 3 trials as a collaborator, "Janssen-Cilag Ltd." with 3 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "CH René Dubos" are "Multiple Myeloma" (6 trials), "Breast Cancer" (5 trials), "Lymphoma" (4 trials), "Myelodysplastic Syndromes" (4 trials) and "Acute Myeloid Leukemia" (3 trials). Many other conditions were trialed in "CH René Dubos" in a lesser frequency.

Most popular intervention types in "CH René Dubos" are "Drug" (66 trials), "Other" (29 trials), "Biological" (9 trials), "Procedure" (9 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Cisplatin" (3 trials), "Endotracheal tubes allowing SSD" (3 trials), "Endotracheal tubes not allowing SSD" (3 trials) and "Nivolumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "CH René Dubos" are 119 trials for "All" genders, 13 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "CH René Dubos". 1 are not yet recruiting, 21 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 85 completed trials in CH René Dubos, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in CH René Dubos, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 20 trials that are defined as “Not Applicable".